| Guided versus standard antiplatelet therapy in patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis M Galli, S Benenati, D Capodanno, F Franchi, F Rollini, D D'Amario, ... The Lancet 397 (10283), 1470-1483, 2021 | 146 | 2021 |
| Coronary atherosclerotic phenotype and plaque healing in patients with recurrent acute coronary syndromes compared with patients with long-term clinical stability: an in vivo … R Vergallo, I Porto, D D’Amario, G Annibali, M Galli, S Benenati, ... JAMA cardiology 4 (4), 321-329, 2019 | 96 | 2019 |
| Microvascular dysfunction in heart failure with preserved ejection fraction D D’Amario, S Migliaro, JA Borovac, A Restivo, R Vergallo, M Galli, ... Frontiers in physiology 10, 1347, 2019 | 90 | 2019 |
| Antiplatelet therapy after percutaneous coronary intervention. DJ Angiolillo, M Galli, JP Collet, A Kastrati, ML O'Donoghue Eurointervention: Journal of Europcr in Collaboration with the Working Group …, 2022 | 86 | 2022 |
| Comparative effects of guided vs. potent P2Y12 inhibitor therapy in acute coronary syndrome: a network meta-analysis of 61 898 patients from 15 randomized trials M Galli, S Benenati, F Franchi, F Rollini, D Capodanno, G Biondi-Zoccai, ... European heart journal 43 (10), 959-967, 2022 | 86 | 2022 |
| Prevention of atherothrombotic events in patients with diabetes mellitus: from antithrombotic therapies to new-generation glucose-lowering drugs G Patti, I Cavallari, F Andreotti, P Calabro, P Cirillo, G Denas, M Galli, ... Nature Reviews Cardiology 16 (2), 113-130, 2019 | 84 | 2019 |
| Safety and efficacy of different prophylactic anticoagulation dosing regimens in critically and non-critically ill patients with COVID-19: a systematic review and meta-analysis … L Ortega-Paz, M Galli, D Capodanno, F Franchi, F Rollini, B Bikdeli, ... European Heart Journal-Cardiovascular Pharmacotherapy 8 (7), 677-686, 2022 | 58 | 2022 |
| Very short vs. long dual antiplatelet therapy after second generation drug-eluting stents in 35 785 patients undergoing percutaneous coronary interventions: a meta-analysis of … S Benenati, M Galli, V De Marzo, F Pescetelli, M Toma, F Andreotti, ... European Heart Journal-Cardiovascular Pharmacotherapy 7 (2), 86-93, 2021 | 46 | 2021 |
| Neoatherosclerosis after drug-eluting stent implantation: a novel clinical and therapeutic challenge JA Borovac, D D’Amario, R Vergallo, I Porto, A Bisignani, M Galli, ... European Heart Journal–Cardiovascular Pharmacotherapy 5 (2), 105-116, 2019 | 44 | 2019 |
| Intracranial haemorrhages vs. stent thromboses with direct oral anticoagulant plus single antiplatelet agent or triple antithrombotic therapy: a meta-analysis of randomized … M Galli, F Andreotti, I Porto, F Crea EP Europace 22 (4), 538-546, 2020 | 41 | 2020 |
| Where does inflammation fit? LM Biasucci, G La Rosa, D Pedicino, A D’Aiello, M Galli, G Liuzzo Current Cardiology Reports 19, 1-10, 2017 | 34 | 2017 |
| Working Group on Thrombosis of the Italian Society of Cardiology. Prevention of atherothrombotic events in patients with diabetes mellitus: from antithrombotic therapies to new … G Patti, I Cavallari, F Andreotti, P Calabrò, P Cirillo, G Denas, M Galli, ... Nat Rev Cardiol 16 (2), 113-130, 2019 | 30 | 2019 |
| Genetic testing in patients undergoing percutaneous coronary intervention: rationale, evidence and practical recommendations M Galli, F Franchi, F Rollini, LH Cavallari, D Capodanno, F Crea, ... Expert review of clinical pharmacology 14 (8), 963-978, 2021 | 29 | 2021 |
| Antithrombotic therapy in the early phase of non-ST-elevation acute coronary syndromes: a systematic review and meta-analysis M Galli, F Andreotti, D D’Amario, R Vergallo, GM Vescovo, L Giraldi, ... European Heart Journal-Cardiovascular Pharmacotherapy 6 (1), 43-56, 2020 | 28 | 2020 |
| Colchicine in ischemic heart disease: the good, the bad and the ugly D D’Amario, D Cappetta, L Cappannoli, G Princi, S Migliaro, G Diana, ... Clinical Research in Cardiology 110, 1531-1542, 2021 | 26 | 2021 |
| Electronic cigarettes and cardiovascular risk: caution waiting for evidence D D’Amario, S Migliaro, JA Borovac, R Vergallo, M Galli, A Restivo, ... European Cardiology Review 14 (3), 151, 2019 | 24 | 2019 |
| Role of platelet function and genetic testing in patients undergoing percutaneous coronary intervention M Galli, F Franchi, F Rollini, DJ Angiolillo Trends in Cardiovascular Medicine, 2021 | 22 | 2021 |
| Precision medicine in interventional cardiology: implications for antiplatelet therapy in patients undergoing percutaneous coronary intervention M Galli, L Ortega-Paz, F Franchi, F Rollini, DJ Angiolillo Pharmacogenomics 23 (13), 723-737, 2022 | 19 | 2022 |
| Experience of remote cardiac care during the COVID‐19 pandemic: the V‐LAP™ device in advanced heart failure D D'Amario, A Restivo, F Canonico, D Rodolico, G Mattia, B Francesco, ... European Journal of Heart Failure 22 (6), 1050, 2020 | 19 | 2020 |
| Randomised trials and meta-analyses of double vs triple antithrombotic therapy for atrial fibrillation-ACS/PCI: a critical appraisal M Galli, F Andreotti, D D'Amario, R Vergallo, RA Montone, G Niccoli, ... International Journal of cardiology. Heart & Vasculature 28, 2020 | 19 | 2020 |
Filippo Creauniversità cattolica del sacro cuore di minoVerified email at policlinicogemelli.it
